Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.

Source:http://linkedlifedata.com/resource/pubmed/id/20682802

Download in:

View as

General Info

PMID
20682802